Author

Johnathon Soro

Stanford Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Aastha PaliD· 1 shared Ada WongiD· 1 shared Anusha K. KalbasiiD· 1 shared Christopher S. SeetiD· 1 shared Deepa Waghray· 1 shared Everett James ModingiD· 1 shared Gay M. CrooksiD· 1 shared Heather Anne N. OganaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aastha PalORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy

Hua Jiang, Sam P. Limsuwannarot, Kayla R. Kulhanek, Aastha Pal, Ossama Labiad, Lea Wenting Rysavy, Ada Wong, Leon Su, Sarah M. Cavender, Johnathon Soro, Stefano Testa, Heather Anne N. Ogana, Deepa Waghray, Pingdong Tao, Kevin M. Jude, , Anusha K. Kalbasi

The paper shows that T cells engineered with IL-9R have better tissue infiltration, stemness, and anti-tumor activity compared to those with an orthogonal IL-9 receptor, due to stronger and more specific JAK/STAT signaling.

Immunity · Nov 21, 2025Peer-reviewedImmunology